Pablo Legorreta
Founder, Chairman of the Board & CEOMr. Pablo Legorreta serves as Co-Founder & Principal at Pharmakon Advisors, LP. He also serves as the Founder, Chairman and CEO of Royalty Pharma plc, which he established in 1996 as a leading investor in pharmaceutical royalties. A dedicated philanthropist, he is the Founder and Chairman of Alianza Médica para la Salud. With extensive expertise in the healthcare and finance industries, he also serves as the Investment Manager of BioPharma Credit PLC, as the Chairman of the Board for ProKidney Corp. and as a Co-Founder and CEO of RP Management, LLC. His extensive leadership portfolio includes roles as a Co-Founder and Director of Sequel Med Tech, LLC, as a Trustee of Hospital for Special Surgery and as a Life Governor of the New York Academy of Sciences. His prior experience includes a distinguished tenure in investment banking at Lazard Frères in Paris and New York. He also acted as a Senior Advisor to Innovation Endeavors Israel. He serves on the boards of Médica Sur, S.A.B. de C.V. and Epizyme, Inc., He holds a degree in Industrial Engineering from Universidad Iberoamericana in Mexico City.
Positions
- Company NameRoyalty Pharma plcStock CodeRPRXPositionFounder, Chairman of the Board & CEOColleagues
- TPTerrance P. CoyneExecutive VP & CFO
- CHChristopher HiteChairman of Partnering & Investments
- MJMarshall Jonathan UristHead of Research & Investments
- GBGreg Butz Executive Vice President of Partnering & Investments
- GNGregory NordenIndependent Director
- TWTed W. LoveLead Independent Director
- DCDavid Charles HodgsonIndependent Director
- BLBonnie L. BasslerIndependent Director
- Company NameProKidney Corp.Stock CodePROKPositionChairman of the BoardColleagues
- BCBruce CulletonCEO & Director
- PLPablo LegorretaChairman of the Board
- JCJames CoulstonChief Financial Officer
- TCTodd C. GirolamoChief Legal Officer & Secretary
- KLKenneth LockeChief Technical Officer
- RWRichard WilliamsChief Information Officer
- WFWilliam F. DoyleLead Independent Director
- AMAlan M. LotvinIndependent Director
- JAJennifer A. FoxIndependent Director
